Deutsch English Français

Contact

EP1218336

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1218336

EP1218336 - MELANIN CONCENTRATING HORMONE ANTAGONIST [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 24.09.2010 Database last updated on 23.04.2024
Most recent event Tooltip	24.09.2010	Application deemed to be withdrawn	published on 27.10.2010 [2010/43]
Applicant(s)	For all designated states Takeda Pharmaceutical Company Limited 1-1, Doshomachi 4-chome, Chuo-ku Osaka / JP
	[2005/04]
Former [2002/27]	For all designated states Takeda Chemical Industries, Ltd. 1-1 Doshomachi 4-chome, Chuo-ku Osaka-shi, Osaka 541-0045 / JP
Inventor(s)	01 / KATO, Kaneyoshi 2-40, Maruyamadai 2-chome Kawanishi-shi, Hyogo 666-0152 / JP
	02 / TERAUCHI, Jun 3-5-204, Hachizuka 3-chome Ikeda-shi, Osaka 563-0024 / JP
	03 / MORI, Masaaki 8-5, Kasuga 3-chome Tsukuba-shi, Ibaraki 305-0821 / JP
	04 / SUZUKI, Nobuhiro 6-51, Fushiharacho, Nishinomiya-shi Hyogo 663-8031 / JP
	05 / SHIMOMURA, Yukio 12-1-410, Matsushiro 3-chome Tsukuba-shi, Ibaraki 305-0035 / JP
	06 / TAKEKAWA, Shiro 12-8-508, Miyanishicho, Nishinomiya-shi Hyogo 662-0976 / JP
	07 / ISHIHARA, Yuji 3-8, Yamada 3-chome, Itami-shi Hyogo 664-0874 / JP
	[2002/27]
Representative(s)	Jones, Nicholas Andrew, et al Withers & Rogers LLP 2 London Bridge London SE1 9RA / GB
	[N/P]
Former [2009/26]	Jones, Nicholas Andrew, et al Withers & Rogers LLP Goldings House 2 Hays Lane London SE1 2HW / GB
Former [2002/27]	Lewin, John Harvey Takeda Patent Office, 11-12 Charles II Street London SW1Y 4QU / GB
Application number, filing date	00961075.9	19.09.2000
	[2002/27]
	WO2000JP06375
Priority number, date	JP19990266298	20.09.1999 Original published format: JP 26629899
	JP19990357889	16.12.1999 Original published format: JP 35788999
	JP20000126272	20.04.2000 Original published format: JP 2000126272
	[2002/27]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO0121577
	Date:	29.03.2001
	Language:	EN
	[2001/13]
	Type:	A2 Application without search report
	No.:	EP1218336
	Date:	03.07.2002
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 29.03.2001 takes the place of the publication of the European patent application.
	[2002/27]
Search report(s)	International search report - published on:	EP	04.10.2001
Classification	IPC:	C07C235/42, C07C235/50, C07C235/56, C07C235/64, C07C235/84	[2009/50]
	CPC:	C07D207/277 (EP,US); C07C217/74 (EP,US); C07C219/28 (EP,US); C07C233/29 (EP,US); C07C233/44 (EP,US); C07C233/80 (EP,US); (+) C07C235/42 (EP,US); C07C235/50 (EP,US); C07C235/56 (EP,US); C07C235/64 (EP,US); C07C235/84 (EP,US); C07C237/40 (EP,US); C07C271/28 (EP,US); C07C275/42 (EP,US); C07C311/21 (EP,US); C07D209/18 (EP,US); C07D209/22 (EP,US); C07D209/42 (EP,US); C07D211/16 (EP,US); C07D211/18 (EP,US); C07D211/22 (EP,US); C07D211/26 (EP,US); C07D211/32 (EP,US); C07D211/52 (EP,US); C07D211/62 (EP,US); C07D211/70 (EP,US); C07D213/56 (EP,US); C07D213/81 (EP,US); C07D213/82 (EP,US); C07D215/14 (EP,US); C07D215/38 (EP,US); C07D233/24 (EP,US); C07D239/28 (EP,US); C07D239/30 (EP,US); C07D261/18 (EP,US); C07D263/14 (EP,US); C07D263/34 (EP,US); C07D265/28 (EP,US); C07D271/06 (EP,US); C07D295/096 (EP,US); C07D295/13 (EP,US); C07D295/185 (EP,US); C07D307/68 (EP,US); C07D307/81 (EP,US); C07D311/58 (EP,US); C07D317/60 (EP,US); C07D319/20 (EP,US); C07D333/24 (EP,US); C07D333/28 (EP,US); C07D333/38 (EP,US); C07D335/16 (EP,US); C07D405/04 (EP,US); C07D405/12 (EP,US); C07D413/04 (EP,US); C07D413/12 (EP,US); C07D493/04 (EP,US); C07C2602/10 (EP,US); C07C2602/12 (EP,US) (-)
	Former IPC [2002/27]	C07C235/00
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2002/27]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	RO	Not yet paid
	SI	Not yet paid
Title	German:	ANTAGONISTEN DES MELANIN-KONZENTRIERENDEN HORMONS	[2002/27]
	English:	MELANIN CONCENTRATING HORMONE ANTAGONIST	[2002/27]
	French:	ANTAGONISTE DE L'HORMONE DE CONCENTRATION DE LA MELANINE	[2002/27]
Entry into regional phase	12.04.2002	National basic fee paid
	12.04.2002	Designation fee(s) paid
	12.04.2002	Examination fee paid
Examination procedure	11.04.2001	Request for preliminary examination filed International Preliminary Examining Authority: EP
	12.04.2002	Amendment by applicant (claims and/or description)
	12.04.2002	Examination requested [2002/27]
	04.08.2003	Despatch of a communication from the examining division (Time limit: M06)
	03.02.2004	Reply to a communication from the examining division
	26.10.2004	Despatch of a communication from the examining division (Time limit: M06)
	14.03.2005	Reply to a communication from the examining division
	16.12.2008	Cancellation of oral proceeding that was planned for 13.01.2009
	16.12.2008	Minutes of oral proceedings despatched
	19.12.2008	Despatch of a communication from the examining division (Time limit: M02)
	13.01.2009	Date of oral proceedings
	13.01.2009	Date of oral proceedings (cancelled)
	17.02.2009	Reply to a communication from the examining division
	07.12.2009	Communication of intention to grant the patent
	20.04.2010	Application deemed to be withdrawn, date of legal effect [2010/43]
	26.05.2010	Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2010/43]
Fees paid	Renewal fee
	12.04.2002	Renewal fee patent year 03
	12.09.2003	Renewal fee patent year 04
	14.09.2004	Renewal fee patent year 05
	14.09.2005	Renewal fee patent year 06
	11.09.2006	Renewal fee patent year 07
	12.09.2007	Renewal fee patent year 08
	15.09.2008	Renewal fee patent year 09
	11.09.2009	Renewal fee patent year 10
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[X]DE2108185 (TROPONWERKE DINKLAGE & CO.) [X] 1-4,8-16,18,28,32 * example -; claim - *;
		[X]DE2448257 (TROPONWERKE DINKLAGE & CO) [X] 1-4,8-16 * example -; claim - *;
		[X]DE2502588 (TROPONWERKE DINKLAGE & CO) [X] 1-4,8-16 * example -; claim - *;
		[XD]EP0533266 (GLAXO GROUP LTD [GB]) [XD] 1,4,5,7,9,10,13-16 * example -; claim - *;
		[XD]WO9532967 (SMITHKLINE BEECHAM PLC [GB], et al) [XD] 1-5,7,13-16 * example -; claim - *;
		[XD]WO9635671 (PFIZER [US], et al) [XD] 1,4,7,13-16,36,38 * example -; claim - *;
		[X]WO9838156 (TAKEDA CHEMICAL INDUSTRIES LTD [JP], et al) [X] 1-7,9-16 * example -; claim - *;
		[X]WO9901127 (SMITHKLINE BEECHAM CORP [US], et al) [X] 1-7,9-16,18,29,32 * example -; claim 4 *;
		[X]EP0920864 (PFIZER PROD INC [US]) [X] 1,4,7,13-17,35-38 * page 3, line 10-14, 30-36; claims; examples *;
		[X] - R. E. MEWSHAW ET AL., "New Generation Dopaminergic Agents. 1. Discovery of a Novel Scaffold Which Embraces the D2 Agonist Pharmacophore. Structure-Activity Relationship of a Series of 2-(Aminomethyl)chromans", J. MED. CHEM., (1997), vol. 40, no. 26, pages 4235 - 56, XP002155829 [X] 1-4,7,9,11-13 * page 4248, right column, example 22b - page 4249, left column, example 39a * DOI: http://dx.doi.org/10.1021/jm9703653
		[X] - A. M. BIRCH ET AL., "N-Substituted (2,3-Dihydro-1,4-benzodioxin-2-yl)methylamine Derivatives as D2 Antagonists/5-HT1A Partial Agonists with Potential as Atypical Antipsychotic Agents", J. MED. CHEM., (1999), vol. 42, no. 17, pages 3342 - 55, XP002155830 [X] 1-4,7,9,11-13 * scheme 8 compound 49 * DOI: http://dx.doi.org/10.1021/jm9910122
		[X] - BEILSTEIN, Beilstein Informationssysteme, XP002155831 [X] 1-4,7,9,11-13 * see BRN 5345411 *
		[ ] - J. CHEM. SOC. PERKIN TRANS. 1, (1992), vol. 5, pages 531 - 32
		[A] - QU D ET AL, "A ROLE FOR MELANIN-CONCENTRATING HORMONE IN THE CENTRAL REGULATION OF FEEDING BEHAVIOUR", NATURE,GB,MACMILLAN JOURNALS LTD. LONDON, (19960321), vol. 380, ISSN 0028-0836, pages 243 - 247, XP002037981 [A] 1-38 * the whole document * DOI: http://dx.doi.org/10.1038/380243a0

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p